IMPLANTS FOR CHILDREN

Version: 2015-08/BAR

background of the bil

The bag-in-the-lens was initially designed and patented as “intraocular lens and method for preventing secondary opacification”.

US Patent Number 6,027,531 EP Patent Number 0916320A2

The clinical study on the bag-in-the-lens started in 2000 after approval by the ethical committee of the Antwerp University Hospital (1/47/136) and got the approval of the Belgian Social Security in 2004.

how to become bil-user

Those surgeons, who are interested in implanting the BIL, can become certified after having performed any of the following training:

1. Wetlab and Instructional Course at the Annual ESCRS meeting on PPCCC. This is a prerequisite requirement in order to partake at the wetlab with the following faculty members: Marie-José Tassignon, Robert Stegmann, Tobias Neuhann, Abhay Vasavada, Rupert Menapace

2. Observership at the Antwerp University Hospital, Department of Ophthalmology

Director Prof. Dr. Marie-José Tassignon

Faculty BIL users Prof. Dr. Marie-José Tassignon, Prof. Dr. Veva De Groot , Dr. Jan Van Looveren, Dr. Stefan Kiekens

Scientific coordinator Danny Mathysen (danny.mathysen@uza.be)

3. Observership at any centers with certified instructors (see list instructors http://www.morcher.com/produkte/bag-in-the-lens.html)

OPHTHALMIC IMPLANTS FOR CHILDREN

MORCHER® GmbH

Kapuzinerweg 12 70374 StuttgartGERMANY

Phone +49 (0) 711 / 95 320 - 0 E-Mail info@morcher.comFax +49 (0) 711 / 95 320 - 80 Web www.morcher.com

FOLDABLE HYDROPHILIC IOLS CAPSULAR RINGSSPECIAL PMMA IOLNo PCO!

BAG-IN-THE-LENS SERIES

TYPE 89A TYPE 89A TORIC TYPE 89D

Indication Adults / Children Adults / Children Children

Total Diameter 7.5 mm 7.5 mm 6.5 mm

Optic Diameter 5.0 mm 5.0 mm | toric 4.5 mm

Standard-Diopter-Range 10.0 – 30.0 D. (0.5 inc.) 10.0 – 30.0 D. (0.5 inc.) 10.0 – 30.0 D. (0.5 inc.)

On-Request-Range*1 8.5 – 9.5 D. (0.5 inc.)30.5 – 35.0 D. (0.5 inc.)

8.5 – 9.5 D. (0.5 inc.) 8.5 – 9.5 D. (0.5 inc.)30.5 – 35.0 D. (0.5 inc.)

Theoretical Standard Power 23.0 D. 23.0 D. 23.0 D.

Cylindrical Power - 0.5 – 8.0 D. (0.5 inc.) -

Theoretical A-Con. (optical) 118.2 118.2 118.2

Theoretical ACD (optical) 5.08 mm 5.08 mm 5.08 mm

Material Hydrophilic Acrylic

Water Content 28.0 %

Filter UV-Filter

Refractive Index 1.46

Injector (recommendation) Up to +20.0 diopters: Medicel NAVIJECTTM 2.2-1P (LP604425W) For all diopters: Medicel NAVIJECTTM 2.8-1P (LP604410W)

Recommended Caliper Ring*3 for ACCC*2

TYPE 5 TYPE 5 TYPE 4L

Feature No PCO in visual field!

Note Surgeons must partake in prerequiste course before implantation!

Advantages ■ experience in IOLs since 1990

■ MORCHER® material development and production

■ excellent optical properties due to high purity materials and perfect surface finish

■ slow and controlled unfolding in the capsular bag

■ hydrophilic property (absorbs water), hence better biocompatibility

■ excellent long-term stability

■ good YAG laster resistance (water content absorbs laser energy)

■ little adhesion of silicon oil after silicon oil surgery

■ no postoperative stimuli

■ no synechiae

■ no PCO (ideal IOL for diabetics)

■ full pupil range

■ no negativ Dysphotopsia

MICROPHTHALMUS

TYPE 27D

Total Diameter 12.0 mm

Optic Diameter 5.0 mm

Position Capsular Bag

Haptic C-Loop | 6°

Standard-Diopter-Range 10.0 – 30.0 D. (0.5 inc.)

On-Request-Range*1 5.0 – 9.5 D. (0.5 inc.)30.5 – 75.0 D. (0.5 inc.)

Theoretical Standard Power 22.0 D.

Theoretical A-Con. (optical) 118.7

Theoretical ACD (optical) 5.37 mm

Material PMMA (Compression molded)

Filter UV-Filter

Refractive Index 1.49

Incision > 5.0 mm

Advantages ■ experience in IOLs since 1949

■ excellent optical properties

■ excellent long-term stability

■ Compression Forged Method (C-F-M) makes the material break proof

CAPSULAR TENSION RING CIONNI RING FOR SCLERAL FIXATION

TYPE 13S TYPE 1S

Size (open) 10.5 mm 10.66 mm

Size (compressed) 9.0 mm 8.5 mm

Zonular Damage up to 4 hours (120°) > 4 hours (120°)

Bulbus Length < 24.0 mm < 24.0 mm

ACCC*2 - 6.0 mm

Suturable arms - one

Injector (recommendation) GEUDER G-32965 Cannot be implanted with an injector!

Material CLEAR PMMA (Compression molded)

Fixation - We recommend the use of 9-0 double armed Prolene sutures

with spatula needles

Advantages ■ expands and stabilizes the capsular bag

■ distributes the pressure to all zonular fibers and prevents one-sided pressure to single zonular fibers

■ centers the IOL more efficiently, even with subsequent capsular bag shrinkage

■ diminishes risk of capsular bag or zonular damage during the surgery

■ facilitates phacoemulsification, cortical aspiration and IOL implantation

■ replaces the need for a scleral IOL

■ simplifies IOL explantation

■ reduces folds of capsule

■ the capsular tension rings have eyelets at both ends to facilitate insertion

■ Compression Forged Method (C-F-M) makes the material break proof

■ expands and stabilizes the capsular bag

■ distributes the pressure to all zonular fibers and prevents one-sided pressure to single zonular fibers

■ centers the IOL more efficiently, even with subsequent capsular bag shrinkage

■ diminishes risk of capsular bag or zonular damage during the surgery

■ facilitates phacoemulsification, cortical aspiration and IOL implantation

■ replaces the need for a scleral IOL

■ simplifies IOL explantation

■ reduces folds of capsule

■ is a secure alternative to capsule supporting hooks

■ Compression Forged Method (C-F-M) makes the material break proof

*1 Other D. on request │ *2 Anterior Continuous Curvolinear Capsulorhexis │ *3 Gauge for Capsulorhexis

IMPLANTS FOR CHILDREN

Version: 2015-08/BAR

background of the bil

The bag-in-the-lens was initially designed and patented as “intraocular lens and method for preventing secondary opacification”.

US Patent Number 6,027,531 EP Patent Number 0916320A2

The clinical study on the bag-in-the-lens started in 2000 after approval by the ethical committee of the Antwerp University Hospital (1/47/136) and got the approval of the Belgian Social Security in 2004.

how to become bil-user

Those surgeons, who are interested in implanting the BIL, can become certified after having performed any of the following training:

1. Wetlab and Instructional Course at the Annual ESCRS meeting on PPCCC. This is a prerequisite requirement in order to partake at the wetlab with the following faculty members: Marie-José Tassignon, Robert Stegmann, Tobias Neuhann, Abhay Vasavada, Rupert Menapace

2. Observership at the Antwerp University Hospital, Department of Ophthalmology

Director Prof. Dr. Marie-José Tassignon

Faculty BIL users Prof. Dr. Marie-José Tassignon, Prof. Dr. Veva De Groot , Dr. Jan Van Looveren, Dr. Stefan Kiekens

Scientific coordinator Danny Mathysen (danny.mathysen@uza.be)

3. Observership at any centers with certified instructors (see list instructors http://www.morcher.com/produkte/bag-in-the-lens.html)

OPHTHALMIC IMPLANTS FOR CHILDREN

MORCHER® GmbH

Kapuzinerweg 12 70374 StuttgartGERMANY

Phone +49 (0) 711 / 95 320 - 0 E-Mail info@morcher.comFax +49 (0) 711 / 95 320 - 80 Web www.morcher.com

FOLDABLE HYDROPHILIC IOLS CAPSULAR RINGSSPECIAL PMMA IOLNo PCO!

BAG-IN-THE-LENS SERIES

TYPE 89A TYPE 89A TORIC TYPE 89D

Indication Adults / Children Adults / Children Children

Total Diameter 7.5 mm 7.5 mm 6.5 mm

Optic Diameter 5.0 mm 5.0 mm | toric 4.5 mm

Standard-Diopter-Range 10.0 – 30.0 D. (0.5 inc.) 10.0 – 30.0 D. (0.5 inc.) 10.0 – 30.0 D. (0.5 inc.)

On-Request-Range*1 8.5 – 9.5 D. (0.5 inc.)30.5 – 35.0 D. (0.5 inc.)

8.5 – 9.5 D. (0.5 inc.) 8.5 – 9.5 D. (0.5 inc.)30.5 – 35.0 D. (0.5 inc.)

Theoretical Standard Power 23.0 D. 23.0 D. 23.0 D.

Cylindrical Power - 0.5 – 8.0 D. (0.5 inc.) -

Theoretical A-Con. (optical) 118.2 118.2 118.2

Theoretical ACD (optical) 5.08 mm 5.08 mm 5.08 mm

Material Hydrophilic Acrylic

Water Content 28.0 %

Filter UV-Filter

Refractive Index 1.46

Injector (recommendation) Up to +20.0 diopters: Medicel NAVIJECTTM 2.2-1P (LP604425W) For all diopters: Medicel NAVIJECTTM 2.8-1P (LP604410W)

Recommended Caliper Ring*3 for ACCC*2

TYPE 5 TYPE 5 TYPE 4L

Feature No PCO in visual field!

Note Surgeons must partake in prerequiste course before implantation!

Advantages ■ experience in IOLs since 1990

■ MORCHER® material development and production

■ excellent optical properties due to high purity materials and perfect surface finish

■ slow and controlled unfolding in the capsular bag

■ hydrophilic property (absorbs water), hence better biocompatibility

■ excellent long-term stability

■ good YAG laster resistance (water content absorbs laser energy)

■ little adhesion of silicon oil after silicon oil surgery

■ no postoperative stimuli

■ no synechiae

■ no PCO (ideal IOL for diabetics)

■ full pupil range

■ no negativ Dysphotopsia

MICROPHTHALMUS

TYPE 27D

Total Diameter 12.0 mm

Optic Diameter 5.0 mm

Position Capsular Bag

Haptic C-Loop | 6°

Standard-Diopter-Range 10.0 – 30.0 D. (0.5 inc.)

On-Request-Range*1 5.0 – 9.5 D. (0.5 inc.)30.5 – 75.0 D. (0.5 inc.)

Theoretical Standard Power 22.0 D.

Theoretical A-Con. (optical) 118.7

Theoretical ACD (optical) 5.37 mm

Material PMMA (Compression molded)

Filter UV-Filter

Refractive Index 1.49

Incision > 5.0 mm

Advantages ■ experience in IOLs since 1949

■ excellent optical properties

■ excellent long-term stability

■ Compression Forged Method (C-F-M) makes the material break proof

CAPSULAR TENSION RING CIONNI RING FOR SCLERAL FIXATION

TYPE 13S TYPE 1S

Size (open) 10.5 mm 10.66 mm

Size (compressed) 9.0 mm 8.5 mm

Zonular Damage up to 4 hours (120°) > 4 hours (120°)

Bulbus Length < 24.0 mm < 24.0 mm

ACCC*2 - 6.0 mm

Suturable arms - one

Injector (recommendation) GEUDER G-32965 Cannot be implanted with an injector!

Material CLEAR PMMA (Compression molded)

Fixation - We recommend the use of 9-0 double armed Prolene sutures

with spatula needles

Advantages ■ expands and stabilizes the capsular bag

■ distributes the pressure to all zonular fibers and prevents one-sided pressure to single zonular fibers

■ centers the IOL more efficiently, even with subsequent capsular bag shrinkage

■ diminishes risk of capsular bag or zonular damage during the surgery

■ facilitates phacoemulsification, cortical aspiration and IOL implantation

■ replaces the need for a scleral IOL

■ simplifies IOL explantation

■ reduces folds of capsule

■ the capsular tension rings have eyelets at both ends to facilitate insertion

■ Compression Forged Method (C-F-M) makes the material break proof

■ expands and stabilizes the capsular bag

■ distributes the pressure to all zonular fibers and prevents one-sided pressure to single zonular fibers

■ centers the IOL more efficiently, even with subsequent capsular bag shrinkage

■ diminishes risk of capsular bag or zonular damage during the surgery

■ facilitates phacoemulsification, cortical aspiration and IOL implantation

■ replaces the need for a scleral IOL

■ simplifies IOL explantation

■ reduces folds of capsule

■ is a secure alternative to capsule supporting hooks

■ Compression Forged Method (C-F-M) makes the material break proof

*1 Other D. on request │ *2 Anterior Continuous Curvolinear Capsulorhexis │ *3 Gauge for Capsulorhexis

FOLDABLE HYDROPHILIC IOLS CAPSULAR RINGSSPECIAL PMMA IOLNo PCO!

BAG-IN-THE-LENS SERIES

TYPE 89A TYPE 89A TORIC TYPE 89D

Indication Adults / Children Adults / Children Children

Total Diameter 7.5 mm 7.5 mm 6.5 mm

Optic Diameter 5.0 mm 5.0 mm | toric 4.5 mm

Standard-Diopter-Range 10.0 – 30.0 D. (0.5 inc.) 10.0 – 30.0 D. (0.5 inc.) 10.0 – 30.0 D. (0.5 inc.)

On-Request-Range*1 8.5 – 9.5 D. (0.5 inc.)30.5 – 35.0 D. (0.5 inc.)

8.5 – 9.5 D. (0.5 inc.) 8.5 – 9.5 D. (0.5 inc.)30.5 – 35.0 D. (0.5 inc.)

Theoretical Standard Power 23.0 D. 23.0 D. 23.0 D.

Cylindrical Power - 0.5 – 8.0 D. (0.5 inc.) -

Theoretical A-Con. (optical) 118.2 118.2 118.2

Theoretical ACD (optical) 5.08 mm 5.08 mm 5.08 mm

Material Hydrophilic Acrylic

Water Content 28.0 %

Filter UV-Filter

Refractive Index 1.46

Injector (recommendation) Up to +20.0 diopters: Medicel NAVIJECTTM 2.2-1P (LP604425W) For all diopters: Medicel NAVIJECTTM 2.8-1P (LP604410W)

Recommended Caliper Ring*3 for ACCC*2

TYPE 5 TYPE 5 TYPE 4L

Feature No PCO in visual field!

Note Surgeons must partake in prerequiste course before implantation!

Advantages ■ experience in IOLs since 1990

■ MORCHER® material development and production

■ excellent optical properties due to high purity materials and perfect surface finish

■ slow and controlled unfolding in the capsular bag

■ hydrophilic property (absorbs water), hence better biocompatibility

■ excellent long-term stability

■ good YAG laster resistance (water content absorbs laser energy)

■ little adhesion of silicon oil after silicon oil surgery

■ no postoperative stimuli

■ no synechiae

■ no PCO (ideal IOL for diabetics)

■ full pupil range

■ no negativ Dysphotopsia

MICROPHTHALMUS

TYPE 27D

Total Diameter 12.0 mm

Optic Diameter 5.0 mm

Position Capsular Bag

Haptic C-Loop | 6°

Standard-Diopter-Range 10.0 – 30.0 D. (0.5 inc.)

On-Request-Range*1 5.0 – 9.5 D. (0.5 inc.)30.5 – 75.0 D. (0.5 inc.)

Theoretical Standard Power 22.0 D.

Theoretical A-Con. (optical) 118.7

Theoretical ACD (optical) 5.37 mm

Material PMMA (Compression molded)

Filter UV-Filter

Refractive Index 1.49

Incision > 5.0 mm

Advantages ■ experience in IOLs since 1949

■ excellent optical properties

■ excellent long-term stability

■ Compression Forged Method (C-F-M) makes the material break proof

CAPSULAR TENSION RING CIONNI RING FOR SCLERAL FIXATION

TYPE 13S TYPE 1S

Size (open) 10.5 mm 10.66 mm

Size (compressed) 9.0 mm 8.5 mm

Zonular Damage up to 4 hours (120°) > 4 hours (120°)

Bulbus Length < 24.0 mm < 24.0 mm

ACCC*2 - 6.0 mm

Suturable arms - one

Injector (recommendation) GEUDER G-32965 Cannot be implanted with an injector!

Material CLEAR PMMA (Compression molded)

Fixation - We recommend the use of 9-0 double armed Prolene sutures

with spatula needles

Advantages ■ expands and stabilizes the capsular bag

■ distributes the pressure to all zonular fibers and prevents one-sided pressure to single zonular fibers

■ centers the IOL more efficiently, even with subsequent capsular bag shrinkage

■ diminishes risk of capsular bag or zonular damage during the surgery

■ facilitates phacoemulsification, cortical aspiration and IOL implantation

■ replaces the need for a scleral IOL

■ simplifies IOL explantation

■ reduces folds of capsule

■ the capsular tension rings have eyelets at both ends to facilitate insertion

■ Compression Forged Method (C-F-M) makes the material break proof

■ expands and stabilizes the capsular bag

■ distributes the pressure to all zonular fibers and prevents one-sided pressure to single zonular fibers

■ centers the IOL more efficiently, even with subsequent capsular bag shrinkage

■ diminishes risk of capsular bag or zonular damage during the surgery

■ facilitates phacoemulsification, cortical aspiration and IOL implantation

■ replaces the need for a scleral IOL

■ simplifies IOL explantation

■ reduces folds of capsule

■ is a secure alternative to capsule supporting hooks

■ Compression Forged Method (C-F-M) makes the material break proof

*1 Other D. on request │ *2 Anterior Continuous Curvolinear Capsulorhexis │ *3 Gauge for Capsulorhexis

IMPLANTS FOR CHILDRENVersion: 2015-08

/BAR

background of the bil

The bag-in-the-lens was initially designed and patented as “intraocular lens and method for preventing secondary opacification”.

US Patent Number 6,027,531 EP Patent Number 0916320A2

The clinical study on the bag-in-the-lens started in 2000 after approval by the ethical committee of the Antwerp University Hospital (1/47/136) and got the approval of the Belgian Social Security in 2004.

how to become bil-user

Those surgeons, who are interested in implanting the BIL, can become certified after having performed any of the following training:

1. Wetlab and Instructional Course at the Annual ESCRS meeting on PPCCC. This is a prerequisite requirement in order to partake at the wetlab with the following faculty members: Marie-José Tassignon, Robert Stegmann, Tobias Neuhann, Abhay Vasavada, Rupert Menapace

2. Observership at the Antwerp University Hospital, Department of Ophthalmology

Director Prof. Dr. Marie-José Tassignon

Faculty BIL users Prof. Dr. Marie-José Tassignon, Prof. Dr. Veva De Groot , Dr. Jan Van Looveren, Dr. Stefan Kiekens

Scientific coordinator Danny Mathysen (danny.mathysen@uza.be)

3. Observership at any centers with certified instructors (see list instructors http://www.morcher.com/produkte/bag-in-the-lens.html)

OPHTHALMIC IMPLANTS FOR CHILDREN

MORCHER® GmbH

Kapuzinerweg 12 70374 StuttgartGERMANY

Phone +49 (0) 711 / 95 320 - 0 E-Mail info@morcher.comFax +49 (0) 711 / 95 320 - 80 Web www.morcher.com